10.46243/jst.2020.v5.i5.pp119-129 registered
Formulation, Development and Evaluation of Topiramate Loaded Niosomes for the Treatment of Epilepsy
Resolves to https://www.jst.org.in/index.php/pub/article/view/313
Held by Longman Publishers (India) · prefix 10.46243 live · DOI address https://doi.org/10.46243/jst.2020.v5.i5.pp119-129
Registered 29 Sep 2026 via crossref · record version 2 · last change 29 Sep 2026, 11:59 PM · record sha256 fbc77056cd19067a…
Resolve ⬇ Record (JSON) ⬇ Kernel Metadata Declaration (XML) Compare with Crossref Cite (APA · BibTeX · RIS · CSL)
Also as schema.org JSON-LD · Turtle · RDF/XML · DataCite XML (not for this record) · Crossref UNIXREF · Crossref UNIXSD — the formats of the DOI content-negotiation service, from this record (which carries what).
What the DOI identifies
JournalArticle — an article in a journal · Digital · Visual · en
Formulation, Development and Evaluation of Topiramate Loaded Niosomes for the Treatment of Epilepsy (PrincipalTitle · en)
Published 2020-10-12
Part of Journal of Science & Technology · ISSN 2456-5660 · issue Volume 5 · pages 119–129
Agents
- Longman Publishers (publisher)
Identifiers DOI 10.46243/jst.2020.v5.i5.pp119-129
Abstract · en
Topiramate (TPM) is an anti-epileptic drug used in the treatment of epilepsy and seizures. The study was designed with three aims. First, to enhance the solubility and bioavailability of BCS class III drug TPM; second, to ease administration of the formulation to the epileptic patient, during an attack, and third, to decrease the dose of drug for enduring treatment. Formulation of TPM niosomes was optimized by changing the concentration of Tween, Labrafil and cholesterol using response surface design. Further the TPM niosomes were prepared by using ether injection method. The formulation was then evaluated for vesicle size, entrapment efficiency and in-vitro drug release study. FTIR and DSC studies were performed for pure drug and optimized batch. The vesicle size of the optimized batch was found to be 0. 35 nm. The %entrapment efficiency and %drug release of optimized batch was found to be 94.64% and 92.027% respectively. From the present study it can be concluded that the developed niosomes of TPM has shown great potential in treatment of epilepsy.
System metadata — ISO 26324:2025, Annex B · DOI Handbook 10.1
Each element by the standard's name (Annex B: reference elements, then administrative) and the Handbook's (in grey), read off the record above.
| Element | Value | In the record |
|---|---|---|
| DOI Name DOI name | 10.46243/jst.2020.v5.i5.pp119-129 | doi |
| Referent Type referentType | Creation | referent |
| Referent Sub-Type referentSubType | JournalArticle — an article in a journal | type |
| Referent Name(s) referentName(s) | Formulation, Development and Evaluation of Topiramate Loaded Niosomes for the Treatment of Epilepsy (PrincipalTitle, en) | titles |
| Basic Metadata basicMetadata | publisher: Longman Publishers published: 2020-10-12 part of: Journal of Science & Technology · ISSN 2456-5660 · no. Volume 5 · pp. 119–129 language: en form: Digital · Visual · Language | agents, dates, container, language, structural_type, modes, characters |
| Referent Identifier(s) alternateIdentifier(s) | none besides the DOI | identifiers, relations (IsSameAs) |
| Registration Authority registrationAuthorityCode | Crossref — issued by Crossref (member 25296); held here as a copy | record.source_agency (our code, ra_doi_name, for names issued here once appointed) |
| Created Date issueDate | 2020-09-24 | record.registered (when the DOI name was first registered) |
| relatedIdentifiers | none needed — the descriptive metadata is in this record | container, relations (only where the descriptive metadata lives at another identifier) |
complete Every System Metadata element is here, with the basic metadata a journal article needs.
Recommended for a journal article and not in this record: its author(s), editor(s) or corporate author · the volume number.
The System Metadata Declaration (JSON) · the Kernel Metadata Declaration (XML) · what each sub-type needs
Cited by — in this registry
No record held in this registry cites this DOI.
Counts only records held in this registry; a citation from a work held elsewhere is not seen here. The list as JSON
References with DOIs
The record lists 18 references; 13 carry a DOI.
| # | Reference | DOI | Held here |
|---|---|---|---|
| 1 | ref1 Rampal RAJERA, Kalpana NAGPAL, Shailendra Kumar SINGH, and Dina Nath Mishra. Niosomes: A Controlled and Novel Drug Delivery System. Biological & Pharmaceutical Bulletin. 2011; 4(7… | 10.1248/bpb.34.945 | not held here |
| 2 | ref2 Namrata Mishra, Vinamrata Srivastava, Anu Kaushik, Vivek Chauhan, Gunjan Srivastava. Formulation and in-vitro evaluation of Niosomes of Aceclofenac. Journal of Scientific and Inno… | 10.31254/jsir.2014.3311 | not held here |
| 3 | ref3 Surendra Agrawal, Vaishali Londhe, Ram Gaud. Niosomes: Layered Delivery System For Drug Targeting. International Journal of Scientific Research. 2014; 3(1): 2277–8179 | 10.15373/22778179/jan2014/143 | not held here |
| 4 | ref4 Devender Sharma, Aashiya Aara E. Ali, Jayshree R. Aate. Niosomes as Novel Drug Delivery System: Review Article. Magazne Pharmatutor Orgnization. 2018; 6(3): 58-65 | 10.29161/pt.v6.i3.2018.58 | not held here |
| 5 | ref5 Veldurthi Ravalika, Abbaraju Krishna Sailaja. Formulation and evaluation of etoricoxib niosomes by thin film hydration technique and ether injection method. Nano Biomed Eng 2017. … | 10.5101/nbe.v9i3.p242-248 | not held here |
| 6 | ref6 Shilpa P. Chaudhari and Vibhavari M. Chatur. Development of Valproic Acid Niosomal in situ Nasal Gel Formulation for Epilepsy. Indian Journal of Pharmaceutical Education and Resea… | 10.5530/ijper.47.3.6 | not held here |
| 7 | ref7 Elaine C. Moreland, David A. Griesemer & Kenton R. Holden. Topiramate for intractable childhood epilepsy. British Epilepsy Association1997; 38(8) :193-194 | 10.1053/seiz.1998.0212 | not held here |
| 8 | ref8 Herrero AI, Del Olmoa N, Gonzalez-Escaladab JR, Solis JM. Two new actions of topiramate: inhibition of depolarizing GABAA-mediated responses and activation of a potassium conducta… | 10.1016/s0028-3908(01)00171-x | not held here |
| 9 | ref9 Professor of Paediatric Neurology and Head of Neurology Unit, Pediatric Hospital A Meyer and University of Florence. Topiramate in the Treatment of Epilepsy–A Review. European Neu… | 10.17925/enr.2006.00.02.40 | not held here |
| 12 | ref12 Shilpa P. Chaudhari and Vibhavari M. Chatur. Development of valproic acid niosomal in situ nasal Gel formulation for epilepsy. Indian Journal of Pharmaceutical Education and Resea… | 10.5530/ijper.47.3.6 | not held here |
| 13 | ref13 Gyati Shilakari Asthana, Parveen Kumar Sharma, and Abhay Asthana. In Vitro and In Vivo Evaluation of Niosomal Formulation for Controlled Delivery of Clarithromycin. https://www.hi… | 10.1155/2016/6492953 | not held here |
| 16 | ref16 Gannu P. Kumar, PogakuRajeshwarrao. Nonionic surfactant vesicular systems for effective drug delivery—an overview.ActaPharmaceuticaSinica B 2011; 1(4): 208-219 | 10.1016/j.apsb.2011.09.002 | not held here |
| 17 | ref17 Tamizharasi S, Dubey A, Rathi V, Rathi JC. Development and characterization of niosomal drug delivery of gliclazid. Journal Young Pharmaceuticals 2009; 1(3):205-209 | 10.4103/0975-1483.57065 | not held here |
Relations
The record states no relation, and no record held here states one with this DOI.
Funding
The record names no funder.
Each funder's page lists every work held here that names it. ROR IDs open at ror.org; Funder Registry IDs resolve at doi.org.
History — the ledger
Every change to this DOI, in order, as it was recorded. Entries are only ever added, never changed or removed.
| # | When | What | By | Changes |
|---|---|---|---|---|
| 1 | 29 Sep 2026, 10:00 PM | register registered at Crossref; record read from api.crossref.org | Administrator (admin) | 96 fields set · sha256 ddadf8c274af… |
| 2 | 29 Sep 2026, 11:59 PM | update record re-read from api.crossref.org | Administrator (admin) | container.titles.0.value: titles.0.value: |
Machine-readable: the history as JSON, with the full record after each change.



